News & Updates

Show Multimedia Only
Clinical insights on best medical therapy for peripheral artery disease

Clinical insights on best medical therapy for peripheral artery disease

02 Dec 2021 byAssoc Prof. Tjun Tang; Dr. Julian Wong

Patients with lower extremity peripheral artery disease (PAD) are at high risk for major adverse cardiovascular events (MACE), major adverse limb events (MALE), mortality, and future major lower extremity amputation (LEA). PAD patients with multivessel disease or relevant comorbidities such as diabetes and kidney failure are at an even higher risks for such events. [Lancet 2018;391:219-229]

02 Dec 2021
Alternative complement pathway upregulated in severe, critical COVID-19

Alternative complement pathway upregulated in severe, critical COVID-19

01 Dec 2021

In patients with severe coronavirus disease 2019 (COVID-19), the leptin and alternative complement pathways are hyperactivated, which in turn might lead to greater inflammation, a new study has found.

01 Dec 2021
Overall survival in metastatic renal cell carcinoma differs by race, gender, treatment

Overall survival in metastatic renal cell carcinoma differs by race, gender, treatment

01 Dec 2021

Among patients with metastatic renal cell carcinoma, there are multiple factors that affect overall survival, including race, gender, treatment, and socioeconomic factors, as reported in a study.

01 Dec 2021